Devices | Funding | Pharmacy Babson Diagnostics $31 Million Series B to DriveRetailization of Customer-First, Highly AccessibleDiagnostic Blood Testing
Devices | Innovation & Technology Drawbridge Health Receives FDA 510(k) Clearance for OneDraw™ A1C Test System